Area of research
Rheumatology · Immunology
Research interest
Research focused on Rheumatoid arthritis and Methotrexate, with related work in Physical therapy, Infliximab, Axial spondyloarthritis. Notable publications include 'Management of Rheumatoid Arthritis With a Digital Health Application', 'Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study', and 'Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study'.
Comparison of the efficacy and safety of methotrexate injection and methotrexate tablets in active RA
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Management of Rheumatoid Arthritis With a Digital Health Application
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study
SAT0734-HPR The effect of rheumatic diseases on work ability: a study of self-assessment of SF-36 in patients with smart system of disease management (SSDM)